Literature DB >> 20685070

Erythropoietin prevents reactive oxygen species generation and renal tubular cell apoptosis at high glucose level.

J Dang1, R Jia, Y Tu, S Xiao, G Ding.   

Abstract

Erythropoietin (EPO) can induce a series of cytoprotective effects in many non-hematopoietic tissues through interaction with the erythropoietin receptor (EPOR), but whether EPO can prevent the overproduction of reactive oxygen species (ROS) and apoptosis in diabetes remains unclear. Here, we report that renal tubular cells possess EPOR and that EPO reduces high glucose-induced oxidative stress in renal tubular cells. Further, we found that EPO inhibited high glucose-induced renal tubular cell apoptosis and that this protective effect was dependent on reduction of Bax/caspase-3 expression as well as elevation of Bcl-2 expression. Our results suggest that EPO can inhibit high glucose-induced renal tubular cell apoptosis through direct effect on anti-oxidative stress and that EPOR may play a key role in this process.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20685070     DOI: 10.1016/j.biopha.2010.06.011

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  28 in total

Review 1.  Programming apoptosis and autophagy with novel approaches for diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2015       Impact factor: 1.990

2.  Erythropoietin employs cell longevity pathways of SIRT1 to foster endothelial vascular integrity during oxidant stress.

Authors:  Jinling Hou; Shaohui Wang; Yan Chen Shang; Zhao Zhong Chong; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2011-08-01       Impact factor: 1.990

Review 3.  Erythropoietin and diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  World J Diabetes       Date:  2015-10-25

4.  mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  World J Diabetes       Date:  2015-03-15

5.  EPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3β, and β-catenin to foster vascular integrity during experimental diabetes.

Authors:  Zhao Zhong Chong; Jinling Hou; Yan Chen Shang; Shaohui Wang; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2011-05       Impact factor: 1.990

Review 6.  Translating cell survival and cell longevity into treatment strategies with SIRT1.

Authors:  K Maiese; Z Z Chong; Yan Chen Shang; S Wang
Journal:  Rom J Morphol Embryol       Date:  2011       Impact factor: 1.033

7.  Prolonged regulatable expression of EPO from an HSV vector using the LAP2 promoter element.

Authors:  Z Wu; M Mata; D J Fink
Journal:  Gene Ther       Date:  2011-11-17       Impact factor: 5.250

Review 8.  Novel directions for diabetes mellitus drug discovery.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang
Journal:  Expert Opin Drug Discov       Date:  2012-10-24       Impact factor: 6.098

Review 9.  Canonical Transient Receptor Potential 6 Channel: A New Target of Reactive Oxygen Species in Renal Physiology and Pathology.

Authors:  Rong Ma; Sarika Chaudhari; Weizu Li
Journal:  Antioxid Redox Signal       Date:  2016-03-18       Impact factor: 8.401

10.  Erythropoietin ameliorates genetamicin-induced renal toxicity: A biochemical and histopathological study.

Authors:  Mahmoud Rafieian-Kopaei; Hamid Nasri; Mehdi Nematbakhsh; Azar Baradaran; Alaleh Gheissari; Hamid Rouhi; Seyed Mohammad Ahmadi Soleimani; Milad Baradaran-Ghahfarokhi; Fatemeh Ghaed-Amini; Mohammadreza Ardalan
Journal:  J Nephropathol       Date:  2012-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.